Page last updated: 2024-08-22

betamethasone-17,21-dipropionate and ketoconazole

betamethasone-17,21-dipropionate has been researched along with ketoconazole in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lacour, JP; Le Fichoux, Y; Ortonne, JP; Vitetta, A1
Feldman, SR; Fleischer, AB; Smith, ES1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1

Trials

1 trial(s) available for betamethasone-17,21-dipropionate and ketoconazole

ArticleYear
Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults.
    Dermatology (Basel, Switzerland), 1992, Volume: 184, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Seborrheic; Female; Gels; Glucocorticoids; Humans; Ketoconazole; Male; Middle Aged; Ointments; Single-Blind Method

1992

Other Studies

2 other study(ies) available for betamethasone-17,21-dipropionate and ketoconazole

ArticleYear
Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994.
    Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:1

    Topics: Administration, Topical; Ambulatory Care; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Clotrimazole; Cost Savings; Cost-Benefit Analysis; Dermatology; Dermatomycoses; Drug Combinations; Drug Costs; Family Practice; Glucocorticoids; Humans; Ketoconazole; Office Visits; Pediatrics; Practice Patterns, Physicians'; Tinea; Treatment Outcome

1998
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004